OPPM
AGIO icon

Opus Point Partners Management’s Agios Pharmaceuticals AGIO Stock Holding History

Opus Point Partners Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,806
Closed -$240K – 56
2019
Q2 		$240K Hold
4,806
– – 0.36% 61
2019
Q1 		$324K Sell
4,806
-309
-6% -$18K 0.44% 55
2018
Q4 		$236K Sell
5,115
-9,987
-66% -$616K 0.52% 33
2018
Q3 		$1.17M Sell
15,102
-731
-5% -$58.8K 2.78% 13
2018
Q2 		$1.33M Sell
15,833
-169
-1% -$14.7K 2.89% 11
2018
Q1 		$1.31M Sell
16,002
-12,702
-44% -$982K 2.57% 11
2017
Q4 		$1.64M Sell
28,704
-4,643
-14% -$292K 1.42% 25
2017
Q3 		$2.23M Buy
33,347
+3,865
+13% +$232K 2% 21
2017
Q2 		$1.52M Sell
29,482
-27,928
-49% -$1.43M 1.39% 30
2017
Q1 		$3.35M Buy
57,410
+1,886
+3% +$90.4K 2.49% 17
2016
Q4 		$2.32M Buy
55,524
+832
+2% +$43.7K 1.85% 25
2016
Q3 		$2.89M Buy
54,692
+11,397
+26% +$496K 1.62% 22
2016
Q2 		$1.81M Sell
43,295
-7,705
-15% -$381K 1.75% 25
2016
Q1 		$2.07M Buy
51,000
+17,000
+50% +$727K 1.6% 25
2015
Q4 		$2.21M Sell
34,000
-12,000
-26% -$787K 1.46% 23
2015
Q3 		$3.25M Buy
+46,000
New +$4.5M 1.79% 23
2015
Q2 		– Sell
-5,000
Closed -$472K – 59
2015
Q1 		$472K Buy
5,000
+584
+13% +$65.4K 0.4% 53
2014
Q4 		$495K Buy
+4,416
New +$394K 0.49% 49

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Opus Point Partners Management's AGIO Position: Q3 2019 in Review

Opus Point Partners Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2019, closing a stake of 4,806 shares — an estimated $240K sold.

Opus Point Partners Management first reported a position in AGIO in Q4 2014 and held it in 18 quarters. The position peaked at $3.35M in Q1 2017. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

  • Opus Point Partners Management reported no remaining Agios Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Opus Point Partners Management sold 4,806 Agios Pharmaceuticals shares in Q3 2019, an estimated $240K.
  • Opus Point Partners Management first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 18 quarters.
  • Opus Point Partners Management's Agios Pharmaceuticals position peaked at $3.35M in Q1 2017.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.